These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 35098344)

  • 1. Efficacy of an ALDH peptide-based dendritic cell vaccine targeting cancer stem cells.
    Liao F; Zhang J; Hu Y; Najafabadi AH; Moon JJ; Wicha MS; Kaspo B; Whitfield J; Chang AE; Li Q
    Cancer Immunol Immunother; 2022 Aug; 71(8):1959-1973. PubMed ID: 35098344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic Efficacy of Cancer Stem Cell Vaccines in the Adjuvant Setting.
    Hu Y; Lu L; Xia Y; Chen X; Chang AE; Hollingsworth RE; Hurt E; Owen J; Moyer JS; Prince ME; Dai F; Bao Y; Wang Y; Whitfield J; Xia JC; Huang S; Wicha MS; Li Q
    Cancer Res; 2016 Aug; 76(16):4661-72. PubMed ID: 27325649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer Stem Cell Vaccination With PD-L1 and CTLA-4 Blockades Enhances the Eradication of Melanoma Stem Cells in a Mouse Tumor Model.
    Zheng F; Dang J; Zhang H; Xu F; Ba D; Zhang B; Cheng F; Chang AE; Wicha MS; Li Q
    J Immunother; 2018 Oct; 41(8):361-368. PubMed ID: 30063587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the immunogenicity of ALDH(high) human head and neck squamous cell carcinoma cancer stem cells in vitro.
    Prince MEP; Zhou L; Moyer JS; Tao H; Lu L; Owen J; Etigen M; Zheng F; Chang AE; Xia J; Wolf G; Wicha MS; Huang S; Ren X; Li Q
    Oral Oncol; 2016 Aug; 59():30-42. PubMed ID: 27424180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer stem cell vaccine inhibits metastases of primary tumors and induces humoral immune responses against cancer stem cells.
    Lu L; Tao H; Chang AE; Hu Y; Shu G; Chen Q; Egenti M; Owen J; Moyer JS; Prince ME; Huang S; Wicha MS; Xia JC; Li Q
    Oncoimmunology; 2015 Mar; 4(3):e990767. PubMed ID: 25949905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer Immunotherapy via Targeting Cancer Stem Cells Using Vaccine Nanodiscs.
    Hassani Najafabadi A; Zhang J; Aikins ME; Najaf Abadi ZI; Liao F; Qin Y; Okeke EB; Scheetz LM; Nam J; Xu Y; Adams D; Lester P; Hetrick T; Schwendeman A; Wicha MS; Chang AE; Li Q; Moon JJ
    Nano Lett; 2020 Oct; 20(10):7783-7792. PubMed ID: 32926633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GRIK2 is a target for bladder cancer stem-like cell-targeting immunotherapy.
    Miyata H; Hirohashi Y; Yamada S; Yanagawa J; Murai A; Hashimoto S; Tokita S; Hori K; Abe T; Kubo T; Tsukahara T; Kanaseki T; Shinohara N; Torigoe T
    Cancer Immunol Immunother; 2022 Apr; 71(4):795-806. PubMed ID: 34405274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aldehyde dehydrogenase-positive melanoma stem cells in tumorigenesis, drug resistance and anti-neoplastic immunotherapy.
    Zhang S; Yang Z; Qi F
    Mol Biol Rep; 2020 Feb; 47(2):1435-1443. PubMed ID: 31838656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer stem cell antigen nanodisc cocktail elicits anti-tumor immune responses in melanoma.
    Aikins ME; Qin Y; Dobson HE; Najafabadi AH; Lyu K; Xu Y; Xin Y; Schwendeman A; Wicha MS; Chang AE; Li Q; Moon JJ
    J Control Release; 2022 Nov; 351():872-882. PubMed ID: 36206945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigen-specific T-cell response from dendritic cell vaccination using cancer stem-like cell-associated antigens.
    Xu Q; Liu G; Yuan X; Xu M; Wang H; Ji J; Konda B; Black KL; Yu JS
    Stem Cells; 2009 Aug; 27(8):1734-40. PubMed ID: 19536809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aldehyde Dehydrogenese-1 High Cancer Stem-like Cells/Cancer-initiating Cells Escape from Cytotoxic T Lymphocytes due to Lower Expression of Human Leukocyte Antigen Class 1.
    Shirosaki T; Kawai N; Ebihara Y; Murai A; Kubo T; Morita R; Murata K; Kanaseki T; Tsukahara T; Shichinohe T; Hirohashi Y; Hirano S; Torigoe T
    Anticancer Res; 2024 May; 44(5):1877-1883. PubMed ID: 38677758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of a novel dendritic-cell vaccine using melanoma and squamous cancer stem cells.
    Li Q; Lu L; Tao H; Xue C; Teitz-Tennenbaum S; Owen JH; Moyer JS; Prince ME; Chang AE; Wicha MS
    J Vis Exp; 2014 Jan; (83):e50561. PubMed ID: 24430104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrin β4-Targeted Cancer Immunotherapies Inhibit Tumor Growth and Decrease Metastasis.
    Ruan S; Lin M; Zhu Y; Lum L; Thakur A; Jin R; Shao W; Zhang Y; Hu Y; Huang S; Hurt EM; Chang AE; Wicha MS; Li Q
    Cancer Res; 2020 Feb; 80(4):771-783. PubMed ID: 31843981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of Whole Cancer Stem Cell-Based Vaccines: A Systematic Review of Preclinical and Clinical Studies.
    Hashemi F; Razmi M; Tajik F; Zöller M; Dehghan Manshadi M; Mahdavinezhad F; Tiyuri A; Ghods R; Madjd Z
    Stem Cells; 2023 Mar; 41(3):207-232. PubMed ID: 36573273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concise Review: Targeting Cancer Stem Cells Using Immunologic Approaches.
    Pan Q; Li Q; Liu S; Ning N; Zhang X; Xu Y; Chang AE; Wicha MS
    Stem Cells; 2015 Jul; 33(7):2085-92. PubMed ID: 25873269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ALDH1A isozymes are markers of human melanoma stem cells and potential therapeutic targets.
    Luo Y; Dallaglio K; Chen Y; Robinson WA; Robinson SE; McCarter MD; Wang J; Gonzalez R; Thompson DC; Norris DA; Roop DR; Vasiliou V; Fujita M
    Stem Cells; 2012 Oct; 30(10):2100-13. PubMed ID: 22887839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dendritic cell based immunotherapy using tumor stem cells mediates potent antitumor immune responses.
    Dashti A; Ebrahimi M; Hadjati J; Memarnejadian A; Moazzeni SM
    Cancer Lett; 2016 Apr; 374(1):175-185. PubMed ID: 26803056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High NRF2 level mediates cancer stem cell-like properties of aldehyde dehydrogenase (ALDH)-high ovarian cancer cells: inhibitory role of all-trans retinoic acid in ALDH/NRF2 signaling.
    Kim D; Choi BH; Ryoo IG; Kwak MK
    Cell Death Dis; 2018 Aug; 9(9):896. PubMed ID: 30166520
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Chen L; Rao W; Chen Y; Xie J
    Oncol Lett; 2024 Nov; 28(5):550. PubMed ID: 39328277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PD-1 blockade enhances the antitumor efficacy of GM-CSF surface-modified bladder cancer stem cells vaccine.
    Shi X; Zhang X; Li J; Mo L; Zhao H; Zhu Y; Hu Z; Gao J; Tan W
    Int J Cancer; 2018 May; 142(10):2106-2117. PubMed ID: 29243219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.